Table 4.
Effects | Sample | β | 95% CI | p value | |
---|---|---|---|---|---|
Indirect effects | |||||
Total indirect effects | Total sample | 0.027 | 0.008 | 0.057 | 0.029 |
Males | 0.023 | −0.020 | 0.081 | 0.395 | |
Females | 0.027 | 0.008 | 0.061 | 0.036 | |
COEN→SE→MA | Total sample | 0.007 | −0.007 | 0.022 | 0.379 |
Males | −0.016 | −0.048 | 0.011 | 0.258 | |
Females | 0.014 | 0.001 | 0.041 | 0.127 | |
COEN→depressive symptoms→MA | Total sample | 0.011 | −0.001 | 0.030 | 0.143 |
Males | 0.019 | −0.003 | 0.055 | 0.203 | |
Females | 0.009 | −0.002 | 0.034 | 0.296 | |
COEN→SE→depressive symptoms→MA | Total sample | 0.009 | 0.003 | 0.022 | 0.035 |
Males | 0.020 | 0.005 | 0.051 | 0.066 | |
Females | 0.004 | 0.000 | 0.017 | 0.247 | |
Direct effects | |||||
COEN→MA | Total sample | 0.061 | −0.013 | 0.135 | 0.118 |
Males | 0.093 | −0.039 | 0.212 | 0.137 | |
Females | 0.032 | −0.066 | 0.127 | 0.513 | |
Total effects | |||||
Direct + indirect effects | Total sample | 0.087 | 0.014 | 0.160 | 0.021 |
Males | 0.116 | -0.012 | 0.221 | 0.052 | |
Females | 0.060 | −0.033 | 0.154 | 0.229 |
Abbreviations: β, standardized coefficient; COEN, community efficacy for non- communicable disease management; SE, self-efficacy; MA, medication adherence. Bold text implies significant effects.